"Please save someone else...as a heart patient, who has survived two interventional angioplasty procedures, I'm beyond salvation..."
I keep repeating this, so one more time won't do any harm.
I'm not here to save anybody, I'm here because I have a hobby of studying likely scam stocks, and those who feed off them, such as their toxic finance partners and their message board promoters.
The fact that I've received thank you emails from folk who were prompted to do their own proper due diligence and didn't make the same mistake as you and lose $50,000 is merely a welcome collateral side-effect.
BTW, if you honestly think that Biophan would have paid off that senior debt without the shareholder pressure that was in part generated by the unanswerable questions that were posed on this MB by parties such as me, then I suspect you could easily lose another $50,000.
The questions you should be asking now are:
1) Why haven't Biophan announced plans to abandon the planned MegaDilution of the float to 800 million shares?
2) How are they going to deal with their new senior debtors, led by one (now widely reviled, but until recently hero-worshipped) Michael Weiner?
3) Why in their recent public announcement have they focused on a "strategy" of acquision rather than applying a laser-like focus on developing the Myotech CSS device? As long as they have FTO, then they don't need to be waiting for any other patent related issues before developing this to the stage where they can get FDA approval. Quite the opposite in fact.
4) Will any new acquisitions result in the syphoning off of tens of millions of dollars from Biophan's balance sheet into private hands (this has happened historically, in spite of attempts by Biophan's suppoerters to pretend it hasn't)?
Interestingly, yet another penny stock company promoted by some of the same parties as Biophan has hit historical new lows recently, and is surely doomed. Check out the IV MB for Intrepid (ITRP) if you want to see how loyal shareholders can be strung along by the agents of toxic financiers until it's too late to emerge with any with any significant remaining capital.
So utterly predictable, but not one whit less sad for all that predictability.
AI
